EP08.02-135 Anti-EGF Antibodies Significantly Improve the Activity of MET and KRAS Inhibitors in Preclinical Models of Non-small Cell Lung Cancer (NSCLC)

Autor: Garcia-Roman, S., Molina-Vila, M.A., Giménez-Capitán, A., Jordana-Ariza, N., Bertran-Alamillo, J., d'Hondt, E., Rosell, R.
Zdroj: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S467-S467
Databáze: ScienceDirect